Skip to main
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is well-positioned for future growth with a strong balance sheet and expansion opportunities. Despite potential challenges, the company's current focus on EBITDA growth and use of AI sets it apart from competitors. The recent OIG report may have minimal impact on investors, and the company's CEO is addressing potential capacity constraints. However, it will be important to monitor industry regulatory changes and the impact of RCD in 2026 on the company's business model. Overall, Encompass Health has a solid foundation and potential for continued success in the post-acute healthcare services sector.

Bears say

Encompass Health is likely to experience future growth due to their strong market position and potential for expansion. However, the company's sole reliance on the inpatient rehabilitation segment makes it vulnerable to any regulatory or reimbursement changes. Additionally, its valuation based on multiples may indicate a potential overvaluation. Therefore, there is a negative outlook on EHC's stock due to potential risks and overvaluation.

Encompass Health (EHC) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $147.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $147.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.